Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

AI system may be able to detect dementia in a day

August 10, 2021 Manufacturing and Production, Medical Communications, Research and Development

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …
News

Researchers develop new method to kill bacteria on medical implants

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …
News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …
News
az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
News
biktarvy-descovy-bottles

Gilead warns of counterfeit HIV medication being distributed in US

August 6, 2021 Medical Communications

Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …
News
sanofi_hq__boetie_hall_small_

Libtayo Phase III Trial stopped early due to significant improvement in overall survival

August 6, 2021 Medical Communications

The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …
News

FDA grants Orphan Drug Designation to sotigalimab for soft tissue sarcoma

August 6, 2021 Medical Communications

The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …
News

Cholesterol pill could cut COVID infections by up to 70%, study finds

August 6, 2021 Medical Communications, Research and Development

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …
News

Study finds pressured oxygen reduces ventilator need in COVID patients

August 5, 2021 Medical Communications

Treating COVID patients with acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation, …
News

Tokyo COVID: Cases surge as Delta variant takes hold, hospital policy U-turn expected

August 4, 2021 Medical Communications, Research and Development

Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …
News

Delta surge: China reports highest rate of new COVID cases since Jan

August 4, 2021 Medical Communications, Research and Development

On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
News

CMA fines Advanz over £100 million over pricing of crucial thyroid drug

July 30, 2021 Medical Communications

The CMA has fined the pharmaceutical company Advanz over £100 million after it charged excessive and unfair prices for supplying …
News

FDA: Viatris’ insulin deemed ‘interchangeable’ biosimilar

July 30, 2021 Medical Communications

Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025